Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Bacillus Calmette-Guérin revaccination in preventing tuberculosis disease: a systematic review and meta-analysis.

International journal of epidemiology·2025
Same author

Nasopharyngeal carriage of Streptococcus pneumoniae among Brazilian children: Interplay with viral co-infection.

PloS one·2025
Same author

High prevalence of 19A pneumococcal serotype carriage during the COVID-19 pandemic in Brazil.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2024
Same author

Community-acquired and healthcare-associated <i>Staphylococcus aureus</i> infections in a pediatric hospital in southern Brazil over 8 years: how common is MRSA?

Frontiers in pediatrics·2023
Same author

Epidemiology and risk factors for mortality among methicillin-resistant Staphylococcus aureus bacteremic patients in Southern Brazil.

PloS one·2023
Same author

Streptococcus pneumoniae serotype 19A from carriers and invasive disease: virulence gene profile and pathogenicity in a Galleria mellonella model.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2023

Related Experiment Video

Updated: Jun 16, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis.

Silvana Superti1, Cícero Armídio Gomes Dias, Pedro Alves d'Azevedo

  • 1Program in Pathology of Health Sciences, Federal University of Porto Alegre, Rua Sarmento Leite 245/204, Porto Alegre, RS, Brazil.

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|February 9, 2010
PubMed
Summary
This summary is machine-generated.

Vancomycin-resistant enterococci (VRE) infections pose a global treatment challenge. This study found that fosfomycin demonstrates significant in vitro activity against VRE, offering a potential therapeutic option.

More Related Videos

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Related Experiment Videos

Last Updated: Jun 16, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Enterococci are common human flora with inherent antimicrobial resistance.
  • Acquired resistance, particularly to vancomycin, leads to challenging infections globally.
  • Limited treatment options exist for vancomycin-resistant enterococci (VRE) infections.

Purpose of the Study:

  • To evaluate the in vitro susceptibility of vancomycin-resistant Enterococcus faecalis (VRE) to fosfomycin.
  • To assess fosfomycin as a potential treatment for VRE infections.

Main Methods:

  • Collected 193 VRE faecalis isolates from four hospitals in Porto Alegre.
  • Assessed fosfomycin susceptibility using E-test and agar diffusion methods.

Main Results:

  • Fosfomycin demonstrated in vitro activity against the majority of VRE faecalis isolates tested.
  • High susceptibility rates to fosfomycin were observed across the studied isolates.

Conclusions:

  • Fosfomycin is a viable therapeutic option for treating infections caused by vancomycin-resistant enterococci.
  • Further clinical studies are warranted to confirm fosfomycin's efficacy in treating VRE infections.